Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

被引：0
|
作者：
Mori, K. [1 ]
Kamiyama, Y. [1 ]
Kondo, T. [1 ]
Kodama, T. [1 ]
机构：
[1] Tochigi Canc Ctr, Div Med Oncol Thorac, Utsunomiya, Tochigi, Japan
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71444-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6616
引用
收藏
页码：393 / 393
页数：1
相关论文
共 50 条
  • [1] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Kiyoshi Mori
    Yukari Kamiyama
    Tetsuro Kondo
    Yasuhiko Kano
    Tetsuro Kodama
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 189 - 195
  • [2] Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy
    Mori, Kiyoshi
    Kamiyama, Yukari
    Kondo, Tetsuro
    Kano, Yasuhiko
    Kodama, Tetsuro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (02) : 189 - 195
  • [3] A phase I–II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens
    Christos Kosmas
    Nicolas Tsavaris
    Konstantinos Syrigos
    Angelos Koutras
    George Tsakonas
    Thomas Makatsoris
    Nicolas Mylonakis
    Athanasios Karabelis
    George P. Stathopoulos
    Haralambos P. Kalofonos
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 51 - 59
  • [4] Gemcitabine Plus Paclitaxel as Second-line Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
    Baykara, Meltem
    Coskun, Ugur
    Berk, Veli
    Ozkan, Metin
    Kaplan, Muhammet Ali
    Benekli, Mustafa
    Karaca, Halit
    Inanc, Mevlude
    Isikdogan, Abdurrahman
    Sevinc, Alper
    Elkiran, Emin Tamer
    Demirci, Umut
    Buyukberber, Suleyman
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (10) : 5119 - 5124
  • [5] Weekly docetaxel as second-line chemotherapy in advanced non-small cell lung cancer: Phase II trial
    Serke, M
    Schoenfeld, N
    Loddenkemper, R
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1211 - 1216
  • [6] Low-dose weekly paclitaxel as second-line treatment for advanced non-small cell lung cancer:: a phase II study
    Juan, O
    Albert, A
    Ordoño, F
    Casany, R
    Carañana, V
    Campos, JM
    Alberola, V
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (11) : 449 - 454
  • [7] A RANDOMIZED PHASE II TRIAL OF CELECOXIB COMBINED WITH PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINE AND WITH ICOTINIB AS SECOND-LINE TREATMENT FOR ADVANCED NON-SMALL CELL LUNG CANCER
    Chu, Tianqing
    Han, Baohui
    Jiang, Liyan
    Zhong, Hua
    Gu, Aiqin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S612 - S613
  • [8] Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer
    Cucevic, B
    Samarzija, M
    Baricevic, D
    Jakopovic, M
    Redzepi, G
    Samija, M
    COLLEGIUM ANTROPOLOGICUM, 2005, 29 (02) : 583 - 588
  • [9] Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC)
    Ardizzoni, A
    Tiseo, M
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 104 - 107
  • [10] A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane plus platinum-based regimens
    Kosmas, Christos
    Tsavaris, Nicolas
    Syrigos, Konstantinos
    Koutras, Angelos
    Tsakonas, George
    Makatsoris, Thomas
    Mylonakis, Nicolas
    Karabelis, Athanasios
    Stathopoulos, George P.
    Kalofonos, Haralambos P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 51 - 59
12345